Get started
Author

Hassen Mahfouf

Observed names: H Mahfouf, H. Mahfouf
ORCID: 0000-0002-7805-5461
Observed ORCID: 0000-0002-7805-5461
OpenAlex ID: A5049224070
All-Trans Retinoic Acid Modulates TLR4/NF- κ B Signaling Pathway Targeting TNF- α and Nitric Oxide Synthase 2 Expression in Colonic Mucosa during Ulcerative Colitis and Colitis Associated Cancer
2017 · Hayet Rafa, Sarra Benkhelifa, et al. · Mediators of Inflammation · 86
PDF
Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: A population-based study
2015 · Farid Cherbal, Hadjer Gaceb, et al. · Breast Disease · 53
Aberrant up-regulation of iNOS/NO system is correlated with an increased abundance of Foxp3+ cells and reduced effector/memory cell markers expression during colorectal cancer: immunomodulatory effects of cetuximab combined with chemotherapy
2019 · Sarra Benkhelifa, Hayet Rafa, et al. · Inflammopharmacology · 20
Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial
2023 · K. Alsaleh, H. Al Zahwahry, et al. · Journal of Cancer Research and Clinical Oncology · 19
PDF
Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients
2017 · Hadjer Gaceb, Farid Cherbal, et al. · Pathology & Oncology Research · 18
Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria
2020 · F Smaili, A Boudjella, et al. · Cancer Treatment and Research Communications · 12
PDF
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial
2021 · Khalid AlSaleh, Heba Al Zahwahry, et al. · JCO Global Oncology · 9
PDF
Effect of dairy products intake on breast cancer risk: A case-control study in Algeria
2018 · Djamil Maliou, Dounia Belmadi, et al. · Nutrition Clinique et Métabolisme · 8
An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction
2021 · İrfan Cicin, Mohammed Oukkal, et al. · European Journal of Breast Health · 6
PDF
Incidence of lung cancer in males and females in Algeria: The lung cancer registry in Algeria (LuCaReAl)
2020 · Adda Bounedjar, Radjâa Benkali, et al. · Cancer Epidemiology · 5
Intravesical gemcitabine (G) single agent as adjuvant chemotherapy in superficial transitional cell carcinoma (TCC) of bladder
2004 · K. Bouzid, R. Ferhat, et al. · Journal of Clinical Oncology · 5
Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study
2022 · Asma‐Lamia Boumehdi, Farid Cherbal, et al. · Annals of Human Genetics · 4
Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant.
2022 · Khalid A. Al-Saleh, Heba Mohamed El Zawahry, et al. · Journal of Clinical Oncology · 4
Germline mutations of the adenomatous polyposis coli (APC) gene in Algerian familial adenomatous polyposis cohort: first report
2022 · Feriel Khider, Farid Cherbal, et al. · Molecular Biology Reports · 4
Middle East and North Africa Registry to Characterize Rate of RAS Testing Status in Newly Diagnosed Patients with Metastatic Colorectal Cancer
2022 · Mohammed Oukkal, Kamel Bouzid, et al. · The Turkish Journal of Gastroenterology · 3
Abstract 2553: Prevalence of BRCA1 germline mutations in Algerian population: implications for genetic testing and counseling
2016 · Farid Cherbal, Hadjer Gaceb, et al. · Cancer Research · 2
Abstract 1003: Cascade genetic testing for hereditary cancer syndromes in Algerian population: pathways to precision medicine
2025 · Farid Cherbal, Chiraz Mehemmai, et al. · Cancer Research · 1
Abstract 887: Clinicopathological and genetic features of breast cancer in Algerian population: A multicenter study
2021 · Farid Cherbal, Leticia Ledmila Saada, et al. · Cancer Research · 1
Prospective evaluation of current RAS mutation testing practices in newly diagnosed metastatic colorectal cancer: Middle East and North Africa Registry (MORE-RAS) Study.
2020 · Mohammed Oukkal, Bouzid Kamel, et al. · Journal of Clinical Oncology · 1
A multicentre, international neoadjuvant (NA), randomized, double-blind phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib in patients with operable luminal breast cancer (SAFIA Trial)
2019 · J-MA Nabholtz, K.A. Alsaleh, et al. · Annals of Oncology · 1
Gemcitabine (G) and cisplatin (C) in the treatment of locally advanced and/or metastatic pancreatic carcinoma
2001 · M. Oukkal, K. Bouzid, et al. · European Journal of Cancer · 1
Multidisciplinary team meeting in digestive cancers: a 6-year experience in an Algerian reference cancer center
2026 · Kamel Bentabak, Mohammed Oukkal, et al. · Pan African Medical Journal
Abstract PS2-02-18: Real-world epidemiologic and biological characterisation of breast cancer in Algeria: A multicenter real world data study on 6044 patients
2026 · A. Bounedjar, M. A. Melzi, et al. · Clinical Cancer Research
Abstract 6102: Clinicopathological and genetics features of endometrial cancer in Algerian women: The first nation-wide study
2024 · Farid Cherbal, Chiraz Mehemmai, et al. · Cancer Research
36P Development of patient-derived explant model as a robust preclinical tool to predict the efficacy of ICB-based immunotherapy in colorectal cancer patients
2024 · H. Rafa, R. Trari, et al. · ESMO Open
Works count: 35
Citation count: 263
H-index: 8
I10-index: 6
Year
Topic
Type